Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar
03 janv. 2023 16h13 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference
29 déc. 2022 08h00 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Update on Proposed Acquisition of Grupo Somar
22 déc. 2022 16h02 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colo., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Procaps Group Reports Third Quarter and Nine Months 2022 Results
14 nov. 2022 17h32 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today...
Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022
08 nov. 2022 15h36 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that it...
Procaps Announces ESG Commitments and Initiatives with Inaugural Report
11 oct. 2022 08h00 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced...
Procaps Group to Participate in the BTG Pactual LatAm CEO Conference
05 oct. 2022 10h15 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced...
Procaps Group Reports Second Quarter and First Half 2022 Results
30 août 2022 06h40 HE
|
Procaps Group, S.A.
Net Revenues Increased 14% year-over-year in the Second Quarter, with Adjusted EBITDA Margin of 24%Constant currency Net Revenues Increased by 18% year-over-year in the First Half, signaling a strong...
Procaps Group Reports Preliminary First Quarter 2022 Results
02 juin 2022 08h14 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, June 02, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today...
Grupo Procaps adquire o Grupo Somar (incluindo Química y Farmacia, Gelcaps e entidades relacionadas) da Advent International, conquistando importante presença no México, segundo maior mercado da região
17 mai 2022 23h01 HE
|
Procaps Group, S.A.
Esta aquisição reafirma a estratégia do Grupo Procaps de se tornar uma das organizações farmacêuticas que mais crescem na América Latina Com receita líquida de US$ 184 milhões no ano fiscal de 2021,...